Differential IL-6 and VEGF secretion in adult and neonatal mesenchymal stem cells: Role of NFkB

Cytokine

Volumn 43, Issue 2, 2008, Pages 215-219

  Novotny, Nathan M ^a   Markel, Troy A ^a   Crisostomo, Paul R ^a   Meldrum, Daniel R ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

IKK inhibitor; Ischemia; LPS; PDTC; TNF

Indexed keywords

I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR; VASCULOTROPIN;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOREGULATION; IMMUNOSTIMULATION; MEDIATOR; MESENCHYMAL STEM CELL; NEWBORN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SUPERNATANT;

AGING; ANIMALS; BONE MARROW; CELLS, CULTURED; I-KAPPA B KINASE; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MALE; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED C57BL; NF-KAPPA B; TUMOR NECROSIS FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 48049093247     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2008.05.015     Document Type: Article

References (22)

1. Xu M., Uemura R., Dai Y., Wang Y., Pasha Z., and Ashraf M. In vitro and in vivo effects of bone marrow stem cells on cardiac structure and function. J Mol Cell Cardiol 42 (2007) 441-448
2. Crisostomo P.R., and Meldrum D.R. Stem cell delivery to the heart: clarifying methodology and mechanism. Crit Care Med 35 (2007) 2654-2656
3. Uemura R., Xu M., Ahmad N., and Ashraf M. Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ Res 98 (2006) 1414-1421
4. Schachinger V., Erbs S., Elsasser A., Haberbosch W., Hambrecht R., Holschermann H., et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 355 (2006) 1210-1221
5. Rossi D.J., Bryder D., Seita J., Nussenzweig A., Hoeijmakers J., and Weissman I.L. Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age. Nature 447 (2007) 725-729
6. Crisostomo P.R., Wang Y., Markel T.A., Wang M., Lahm T., and Meldrum D.R. Human mesenchymal stem cells stimulated by TNF, LPS, or hypoxia produce growth factors by an NFkB but not JNK dependent mechanism. Am J Physiol Cell Physiol 294 (2008) 675-682
7. Peister A., Mellad J.A., Larson B.L., Hall B.M., Gibson L.F., and Prockop D.J. Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood 103 (2004) 1662-1668
8. Dinarello C.A., and Pomerantz B.J. Proinflammatory cytokines in heart disease. Blood Purif 19 (2001) 314-321
9. Zucali J.R., Broxmeyer H.E., Gross M.A., and Dinarello C.A. Recombinant human tumor necrosis factors alpha and beta stimulate fibroblasts to produce hemopoietic growth factors in vitro. J Immunol 140 (1988) 840-844
10. Crisostomo P.R., Wang M., Markel T.A., Lahm T., Abarbanell A.M., Herrmann J.L., et al. Stem cell mechanisms and paracrine effects: potential in cardiac surgery. Shock 28 (2007) 375-383
11. Meng X., Brown J.M., Ao L., Shames B.D., Banerjee A., and Harken A.H. Reduction of infarct size in the rat heart by LPS preconditioning is associated with expression of angiogenic growth factors and increased capillary density. Shock 12 (1999) 25-31
12. Lahm T., Crisostomo P.R., Markel T.A., Wang M., Lillemoe K.D., and Meldrum D.R. The critical role of vascular endothelial growth factor in pulmonary vascular remodeling after lung injury. Shock 28 (2007) 4-14
13. Rosinberg A., Khan T.A., Sellke F.W., and Laham R.J. Therapeutic angiogenesis for myocardial ischemia. Expert Rev Cardiovasc Ther 2 (2004) 271-283
14. Symes J.F. Focal angiogenic therapy for myocardial ischemia. J Card Surg 15 (2000) 283-290
15. Sellke F.W., and Ruel M. Vascular growth factors and angiogenesis in cardiac surgery. Ann Thorac Surg 75 (2003) S685-S690
16. Lekas M., Lekas P., Latter D.A., Kutryk M.B., and Stewart D.J. Growth factor-induced therapeutic neovascularization for ischaemic vascular disease: time for a re-evaluation?. Curr Opin Cardiol 21 (2006) 376-384
17. Wairiuko G.M., Crisostomo P.R., Wang M., Morrell E.D., Meldrum K.K., Lillemoe K.D., et al. Stem cells improve right ventricular functional recovery after acute pressure overload and ischemia reperfusion injury. J Surg Res 141 (2007) 241-246
18. Niagara M.I., Haider H.K., Jiang S., and Ashraf M. Pharmacologically preconditioned skeletal myoblasts are resistant to oxidative stress and promote angiomyogenesis via release of paracrine factors in the infarcted heart. Circ Res 100 (2007) 545-555
19. Kamimura D., Ishihara K., and Hirano T. IL-6 signal transduction and its physiological roles: the signal orchestration model. Rev Physiol Biochem Pharmacol 149 (2003) 1-38
20. Parmar J.H., Aslam M., and Standfield N.J. Peripheral arterial revascularization causing parallel increased activity of pro- and anti-inflammatory mediators. Int Angiol 26 (2007) 8-11
21. Dai R.P., Dheen S.T., He B.P., and Tay S.S.W. Differential expression of cytokines in the rat heart in response to sustained volume overload. Eur J Heart Fail 6 (2004) 693-703
22. Leemans J.C., Vervoordeldonk M.J.B.M., Florquin S., van Kessel K.P., and van der Poll T. Differential role of interleukin-6 in lung inflammation induced by lipoteichoic acid and peptidoglycan from Staphylococcus aureus. Am J Respir Crit Care Med 165 (2002) 1445-1450